- Perspective oncolytics of plant origin +1Publication without faculty affiliation
- Oncolytic viruses and cancer treatment2023 | Faculty of Science
- Reolysin(R) - Oncolytic virus2008 | Second Faculty of Medicine
- Trial Watch-Oncolytic viruses and cancer therapy2016 | Second Faculty of Medicine
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors2018 | Second Faculty of Medicine
- Reovirus - possible therapy of cancer2006 | Second Faculty of Medicine
- Anticancer Efficiency of Reovirus in Normoxia and Hypoxia2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells2008 | Second Faculty of Medicine
- Trial Watch-Immunostimulation with cytokines in cancer therapy2016 | Second Faculty of Medicine
- Classification of current anticancer immunotherapies2014 | Second Faculty of Medicine
- Virotherapy: The viruses that can cure2010 | Faculty of Science
- Epigenetic agents in combined anticancer therapy2018 | First Faculty of Medicine
- Advances in the development of anti-cancer vaccines2018 | Second Faculty of Medicine
- In vitro and in vivo effects of reovirus on HPV16-transformed mice cells2010 | Second Faculty of Medicine
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications2016 | Second Faculty of Medicine
- Complex treatment of melanoma2019 | First Faculty of Medicine
- Multimutated herpes simplex virus G207 is a potent inhibitor of angiogenesis2004 | Second Faculty of Medicine
- LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells2021 | Second Faculty of Medicine
- Advances in Immunotherapy of Malignant Melanoma2017 | Publication without faculty affiliation
- Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 102022 | Faculty of Science